Company Filing History:
7 out of 3,540 
1 out of 1,217 
Years Active: 1999-2013
Title: The Innovative Contributions of Carmie Kirk Acosta
Introduction
Carmie Kirk Acosta is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiprogestational agents. With a total of 8 patents to his name, Acosta's work has the potential to impact various medical treatments.
Latest Patents
Among his latest patents is the invention titled "Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents." This invention relates to compounds that can be used to antagonize endogenous progesterone and treat conditions such as endometriosis, dysmenorrhea, and hormone-dependent tumors. Another significant patent is for "21-substituted progesterone derivatives as new antiprogestational agents," which also focuses on compounds that can be utilized for various medical applications, including contraception and inducing labor.
Career Highlights
Carmie Kirk Acosta has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services. His experience in these institutions has allowed him to contribute to important research and development in the medical field.
Collaborations
Throughout his career, Acosta has collaborated with notable colleagues such as Hyun K Kim and Richard P Blye. These partnerships have likely enhanced the quality and impact of his inventions.
Conclusion
Carmie Kirk Acosta's innovative work in the field of pharmaceuticals demonstrates his commitment to advancing medical science. His patents reflect a dedication to improving healthcare outcomes through targeted therapies.